We are live on ! Find out more
PODD icon

Insulet

162 hedge funds and large institutions have $2.26B invested in Insulet in 2015 Q4 according to their latest regulatory filings, with 32 funds opening new positions, 54 increasing their positions, 56 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

146% more first-time investments, than exits

New positions opened: 32 | Existing positions closed: 13

63% more call options, than puts

Call options by funds: $3.58M | Put options by funds: $2.2M

44% more capital invested

Capital invested by funds: $1.57B → $2.26B (+$695M)

20% more funds holding in top 10

Funds holding in top 10: 56 (+1)

13% more funds holding

Funds holding: 144162 (+18)

4% less repeat investments, than reductions

Existing positions increased: 54 | Existing positions reduced: 56

Holders
162
Holders Change
+18
Holders Change %
+12.5%
% of All Funds
4.25%
Holding in Top 10
6
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+20%
% of All Funds
0.16%
New
32
Increased
54
Reduced
56
Closed
13
Calls
$3.58M
Puts
$2.2M
Net Calls
+$1.38M
Net Calls Change
+$710K
Name Holding Trade Value Shares
Change
Change in
Stake
QT
176
Quantbot Technologies
New York
-$9K -371 Closed

PODD Hedge Fund Activity: Q4 2015 in Review

162 of the 3,812 institutional investors tracked by Wall St. Rank reported a position in Insulet (PODD) for Q4 2015, worth a combined $2.26B — up 44% from $1.57B a quarter earlier.

Buyers outnumbered sellers: 32 funds opened new PODD positions and 13 closed out — a net gain of 19 holders — while 54 added to existing stakes and 56 trimmed.

The largest buyer was Capital Research Global Investors, adding an estimated $60.8M. The largest seller was Bridger Management, exiting entirely with an estimated $56.1M sold.

  • 162 institutional investors held Insulet (PODD) as of Q4 2015, up from 144 in Q3 2015.
  • Funds reported $2.26B of Insulet stock for Q4 2015, up 44% quarter-over-quarter.
  • 32 funds opened new Insulet positions in Q4 2015 and 13 closed out, a net change of +19 holders.
  • The largest Insulet buyer in Q4 2015 was Capital Research Global Investors, an estimated $60.8M added.
  • The largest Insulet seller in Q4 2015 was Bridger Management, an estimated $56.1M sold.

Based on aggregated 13F filings for Q4 2015.